MR Imaging Presentation of Intracranial Disease Associated with Langerhans Cell Histiocytosis

References

1. ↵
   A multicentre retrospective survey of Langerhans’ cell histiocytosis: 348 cases observed between 1983 and 1993: The French Langerhans’ Cell Histiocytosis Study Group. Arch Dis Child 1996;75:17–24

   Abstract/FREE Full Text
2. ↵
   Arceci RJ. The histiocytoses: the fall of the Tower of Babel. Eur J Cancer 1999;35:747–767
3. ↵
   Egeler RM, D’Angio GJ. Langerhans cell histiocytosis. J Pediatr 1995;127:1–11

   CrossRefPubMedWeb of Science
4. ↵
   Grois N, Flucher-Wolfram B, Heitger A, Mostbeck GH, Hofmann J, Gadner H. Diabetes insipidus in Langerhans cell histiocytosis: results from the DAL-HX 83 study. Med Pediatr Oncol 1995;24:248–256

   PubMed
5. ↵
   Nanduri VR, Bareille P, Pritchard J, Stanhope R. Growth and endocrine disorders in multisystem Langerhans’ cell histiocytosis. Clin Endocrinol (Oxf) 2000;53:509–515

   CrossRefPubMed
6. ↵
   Grois N, Barkovich AJ, Rosenau W, Ablin AR. Central nervous system disease associated with Langerhans’ cell histiocytosis. Am J Pediatr Hematol Oncol 1993;15:245–254

   PubMedWeb of Science
7. ↵
   Bergmann M, Yuan Y, Bruck W, Palm KV, Rohkamm R. Solitary Langerhans cell histiocytosis lesion of the parieto-occipital lobe: a case report and review of the literature. Clin Neurol Neurosurg 1997;99:50–55

   CrossRefPubMedWeb of Science
8. Cervera A, Madero L, Garcia Penas JJ, et al. CNS sequelae in Langerhans cell histiocytosis: progressive spinocerebellar degeneration as a late manifestation of the disease. Pediatr Hematol Oncol 1997;14:577–584

   PubMedWeb of Science
9. ↵
   Saatci I, Baskan O, Haliloglu M, Aydingoz U. Cerebellar and basal ganglion involvement in Langerhans cell histiocytosis. Neuroradiology 1999;41:443–446

   CrossRefPubMedWeb of Science
10. Hund E, Steiner H, Jansen O, Sieverts H, Sohl G, Essig M. Treatment of cerebral Langerhans cell histiocytosis. J Neurol Sci 1999;171:145–152

    CrossRefPubMed
11. ↵
    Barthez MA, Araujo E, Donadieu J. Langerhans cell histiocytosis and the central nervous system in childhood: evolution and prognostic factors. Results of a collaborative study. J Child Neurol 2000;15:150–156

    Abstract/FREE Full Text
12. ↵
    Braier J, Chantada G, Rosso D, et al. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution. Pediatr Hematol Oncol 1999;16:377–385

    CrossRefPubMedWeb of Science
13. ↵
    Kaltsas GA, Powles TB, Evanson J, et al. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 2000;85:1370–1376

    CrossRefPubMedWeb of Science
14. ↵
    Grois N, Tsunematsu Y, Barkovich AJ, Favara BE. Central nervous system disease in Langerhans cell histiocytosis. Br J Cancer Suppl 1994;23:S24–S28

    PubMed
15. ↵
    Maghnie M, Cosi G, Genovese E, et al. Central diabetes insipidus in children and young adults. N Engl J Med 2000;343:998–1007

    CrossRefPubMedWeb of Science
16. ↵
    Grois NG, Favara BE, Mostbeck GH, Prayer D. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin N Am 1998;12:287–305

    CrossRefPubMedWeb of Science
17. ↵
    Hand A. Defects of Membraneous Bones, Exophthalmus and Polyuria in Childhood: Is it Dyspituitarism? Am J Med Sci 1921;162:509–515

    CrossRefWeb of Science
18. Holbach LM, Colombo F, Heckmann JG, Strauss C, Dobig C. [Langerhans-cell histiocytosis of the orbit; diagnosis, treatment and outcome in three patients—children and adults]. Klin Monatsbl Augenheilkd 2000;217:370–373

    CrossRefPubMed
19. ↵
    Char DH, Ablin A, Beckstead J. Histiocytic disorders of the orbit. Ann Ophthalmol 1984;16:867–863

    PubMedWeb of Science
20. ↵
    Gordts F, Clement PA, Buisseret T. Prevalence of paranasal sinus abnormalities on MRI in a non-ENT population. Acta Otorhinolaryngol Belg 1996;50:167–170

    PubMed
21. ↵
    Maly PV, Sundgren PC. Changes in paranasal sinus abnormalities found incidentally on MRI. Neuroradiology 1995;37:471–474

    PubMedWeb of Science
22. ↵
    Ganong WF. Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin Exp Pharmacol Physiol 2000;27:422–427

    CrossRefPubMedWeb of Science
23. ↵
    Millington GW, Tung YC, Hewson AK, O’Rahilly S, Dickson SL. Differential effects of alpha-, beta- and gamma(2)-melanocyte-stimulating hormones on hypothalamic neuronal activation and feeding in the fasted rat. Neuroscience 2001;108:437–445

    CrossRefPubMedWeb of Science
24. ↵
    Maghnie M, Genovese E, Bernasconi S, Binda S, Arico M. Persistent high MR signal of the posterior pituitary gland in central diabetes insipidus. AJNR Am J Neuroradiol 1997;18:1749–1752

    Abstract
25. ↵
    Holder CA, Elster AD. Magnetization transfer imaging of the pituitary: further insights into the nature of the posterior ‘bright spot&quot. J Comput Assist Tomogr 1997;21:171–174

    CrossRefPubMed
26. Kucharczyk J, Kucharczyk W, Berry I, et al. Histochemical characterization and functional significance of the hyperintense signal on MR images of the posterior pituitary. AJR Am J Roentgenol 1989;152:153–157

    PubMedWeb of Science
27. ↵
    Kurokawa H, Fujisawa I, Nakano Y, et al. Posterior lobe of the pituitary gland: correlation between signal intensity on T1-weighted MR images and vasopressin concentration. Radiology 1998;207:79–83

    PubMedWeb of Science
28. ↵
    Bullmann C, Faust M, Hoffmann A, et al. Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis. Eur J Endocrinol 2000;142:365–372

    Abstract
29. Czernichow P, Garel C, Leger J. Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus. Horm Res 2000;53(Suppl 3):61–64
30. Masera N, Grant DB, Stanhope R, Preece MA. Diabetes insipidus with impaired osmotic regulation in septo-optic dysplasia and agenesis of the corpus callosum. Arch Dis Child 1994;70:51–53

    Abstract/FREE Full Text
31. Frangoul HA, Shaw DW, Hawkins D, Park J. Diabetes insipidus as a presenting symptom of acute myelogenous leukemia. J Pediatr Hematol Oncol 2000;22:457–459

    CrossRefPubMed
32. Katzman GL, Langford CA, Sneller MC, Koby M, Patronas NJ. Pituitary involvement by Wegener’s granulomatosis: a report of two cases. AJNR Am J Neuroradiol 1999;20:519–523

    Abstract/FREE Full Text
33. Gagliardi PC, Bernasconi S, Repaske DR. Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly23–>Val in neurophysin II. J Clin Endocrinol Metab 1997;82:3643–3646

    CrossRefPubMedWeb of Science
34. ↵
    Maghnie M. Lymphocytic hypophysitis and central diabetes insipidus during adolescence: what are the criteria for diagnosis? Eur J Pediatr 1998;157:693–694

    CrossRefPubMed
35. ↵
    Sumida M, Barkovich AJ, Newton TH. Development of the pineal gland: measurement with MR. AJNR Am J Neuroradiol 1996;17:233–236

    Abstract
36. ↵
    Sugiyama K, Uozumi T, Kiya K, et al. Intracranial germ-cell tumor with synchronous lesions in the pineal and suprasellar regions: report of six cases and review of the literature. Surg Neurol 1992;38:114–120

    CrossRefPubMedWeb of Science
37. ↵
    Brunberg JA. Hyperintense basal ganglia on T1-weighted MR in a patient with Langerhans cell histiocytosis. AJNR Am J Neuroradiol 1996;17:1193–1194

    FREE Full Text
38. ↵
    Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94–98

    CrossRefPubMedWeb of Science
39. ↵
    Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000;54:697–702

    Abstract/FREE Full Text
40. ↵
    Schwarz J, Weis S, Kraft E, et al. Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy. J Neurol Neurosurg Psychiatry 1996;60:98–101

    Abstract/FREE Full Text
41. ↵
    Wenning GK, Braune S. Multiple system atrophy: pathophysiology and management. CNS Drugs 2001;15:839–852

    CrossRefPubMed
42. ↵
    Schick S, Gahleitner A, Wober-Bingol C, et al. Virchow-Robin spaces in childhood migraine. Neuroradiology 1999;41:283–287

    CrossRefPubMedWeb of Science
43. Artigas J, Poo P, Rovira A, Cardo E. Macrocephaly and dilated Virchow-Robin spaces in childhood. Pediatr Radiol 1999;29:188–190

    CrossRefPubMed
44. Rollins NK, Deline C, Morriss MC. Prevalence and clinical significance of dilated Virchow-Robin spaces in childhood. Radiology 1993;189:53–57

    PubMed
45. Berkefeld J, Enzensberger W, Lanfermann H. Cryptococcus meningoencephalitis in AIDS: parenchymal and meningeal forms. Neuroradiology 1999;41:129–133

    CrossRefPubMed
46. Kanpittaya J, Jitpimolmard S, Tiamkao S, Mairiang E. MR findings of eosinophilic meningoencephalitis attributed to Angiostrongylus cantonensis. AJNR Am J Neuroradiol 2000;21:1090–1094

    Abstract/FREE Full Text
47. ↵
    Lynch SA, Hall K, Precious S, Wilkies AO, Hurst JA. Two further cases of Sener syndrome: frontonasal dysplasia and dilated Virchow-Robin spaces. J Med Genet 2000;37:466–470

    FREE Full Text
48. ↵
    Aloisi F, Ria F, Adorini L. Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol Today 2000;21:141–147

    CrossRefPubMedWeb of Science
49. ↵
    Weller RO. Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis. J Neuropathol Exp Neurol 1998;57:885–894

    CrossRefPubMedWeb of Science
50. ↵
    Weller RO, Engelhardt B, Phillips MJ. Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol 1996;6:275–288

    CrossRefPubMedWeb of Science
51. ↵
    Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000;123(Pt 12):2407–2422
52. ↵
    Kolodny EH. Dysmyelinating and demyelinating conditions in infancy. Curr Opin Neurol Neurosurg 1993;6:379–386

    PubMed
53. ↵
    Lovblad K, Kelkar P, Ozdoba C, Ramelli G, Remonda L, Schroth G. Pure methotrexate encephalopathy presenting with seizures: CT and MRI features. Pediatr Radiol 1998;28:86–91

    CrossRefPubMedWeb of Science
54. Rabin BM, Meyer JR, Berlin JW, Marymount MH, Palka PS, Russell EJ. Radiation-induced changes in the central nervous system and head and neck. Radiographics 1996;16:1055–1072

    PubMedWeb of Science
55. ↵
    Hertzberg H, Huk WJ, Ueberall MA, et al. CNS late effects after ALL therapy in childhood, I: Neuroradiological findings in long-term survivors of childhood ALL–an evaluation of the interferences between morphology and neuropsychological performance—The German Late Effects Working Group. Med Pediatr Oncol 1997;28:387–400

    CrossRefPubMedWeb of Science
56. ↵
    Su M, Yoshida Y, Hirata Y, Satoh Y, Nagata K. Degeneration of the cerebellar dentate nucleus in corticobasal degeneration: neuropathological and morphometric investigations. Acta Neuropathol (Berl) 2000;99:365–370

    CrossRefPubMed
57. ↵
    Kumada S, Hayashi M, Mizuguchi M, Nakano I, Morimatsu Y, Oda M. Cerebellar degeneration in hereditary dentatorubral-pallidoluysian atrophy and Machado-Joseph disease. Acta Neuropathol (Berl) 2000;99:48–54

    CrossRefPubMed
58. ↵
    Mizusawa H, Yen SH, Hirano A, Llena JF. Pathology of the dentate nucleus in progressive supranuclear palsy: a histological, immunohistochemical and ultrastructural study. Acta Neuropathol (Berl) 1989;78:419–428

    CrossRefPubMed
59. ↵
    Farina L, Nardocci N, Bruzzone MG, et al. Infantile neuroaxonal dystrophy: neuroradiological studies in 11 patients. Neuroradiology 1999;41:376–380

    CrossRefPubMedWeb of Science
60. ↵
    Pena JA, Molina O, Cardozo J. Hallervorden-Spatz disease: two new early childhood onset cases. J Child Neurol 2000;15:30–32

    CrossRefPubMed
61. ↵
    Koeppen AH, Dickson AC, Lamarche JB, Robitaille Y. Synapses in the hereditary ataxias. J Neuropathol Exp Neurol 1999;58:748–764

    PubMedWeb of Science
62. ↵
    Vernino S, Lennon VA. New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity. Ann Neurol 2000;47:297–305

    CrossRefPubMedWeb of Science
63. ↵
    Hahn A, Claviez A, Brinkmann G, Altermatt HJ, Schneppenheim R, Stephani U. Paraneoplastic cerebellar degeneration in pediatric Hodgkin disease. Neuropediatrics 2000;31:42–44

    CrossRefPubMed
64. ↵
    Antunes NL, Khakoo Y, Matthay KK, et al. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J Pediatr Hematol Oncol 2000;22:315–320

    CrossRefPubMedWeb of Science
65. ↵
    Tanji K, Vu TH, Schon EA, DiMauro S, Bonilla E. Kearns-Sayre syndrome: unusual pattern of expression of subunits of the respiratory chain in the cerebellar system. Ann Neurol 1999;45:377–383

    CrossRefPubMedWeb of Science
66. ↵
    Zhou L, Chomyn A, Attardi G, Miller CA. Myoclonic epilepsy and ragged red fibers (MERRF) syndrome: selective vulnerability of CNS neurons does not correlate with the level of mitochondrial tRNAlys mutation in individual neuronal isolates. J Neurosci 1997;17:7746–7753

    Abstract/FREE Full Text
67. ↵
    Barkhof F, Verrips A, Wesseling P, et al. Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 2000;217:869–876

    PubMedWeb of Science
68. ↵
    Breidahl WH, Ives FJ, Khangure MS. Cerebral and brain stem Langerhans cell histiocytosis. Neuroradiology 1993;35:349–351

    CrossRefPubMedWeb of Science